Med schools urged to disclose pharma links

MEDICAL schools would have to declare the full extent of their financial relationships with pharmaceutical companies on a government website under a proposal touted by a leading academic.

Researchers from the University of Sydney have called for the dramatic measure after conducting what is understood to be the first Australian study into conflicts of interest between medical schools and drug companies.

Researchers analysed the policies of Australia’s 20 medical schools in seven areas: gifts from pharmaceuticals; consulting relationships; funded speaking relationships; disclosure; on-campus sponsorship; travel perks; and the curriculum itself.

Co-authored by Professor  Martin Tattersall, of the University of Sydney medical faculty, the study found Australia’s medical schools were far behind their US counterparts when it came to policies governing relationships with pharmaceutical companies.

For example, the study revealed